News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Smith David Ross
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2023 |
3
| Smith David Ross (Director) has filed a Form 3 on Fortrea Holdings Inc. |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2022 |
4
| Smith David Ross (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Granted 12,321 shares
@ $0 Paid exercise price by delivering 5,364 shares
@ $312.24, valued at
$1.7M
|
|
08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2020 |
4
| Smith David Ross (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Granted 2,176 shares
@ $0 Granted 7,261 options to buy
@ $179.66, valued at
$1.3M
|
|
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/13/2019 |
4
| Smith David Ross (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Sold 95 shares
@ $128.85, valued at
$12.2k
Sold 119 shares
@ $129.04, valued at
$15.4k
Sold 123 shares
@ $129.67, valued at
$15.9k
Sold 114 shares
@ $130.32, valued at
$14.9k
Sold 109 shares
@ $130.44, valued at
$14.2k
Sold 116 shares
@ $130.51, valued at
$15.1k
Sold 105 shares
@ $130.64, valued at
$13.7k
Sold 9 shares
@ $130.79, valued at
$1.2k
Sold 4 shares
@ $130.84, valued at
$523.4 Sold 8 shares
@ $130.905, valued at
$1k
Sold 107 shares
@ $130.91, valued at
$14k
|
|
08/12/2019 |
4
| Smith David Ross (Corporate Executive VP & CFO) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Txns:
| Paid exercise price by delivering 337 shares
@ $132.6, valued at
$44.7k
|
|
03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|